CareRx Corporation (TSX: CRRX)
CRRX trades on the Toronto Stock Exchange in Life Sciences, headquartered in Ontario. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of October 31, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for CRRX.TO, last bar 2026-11-13, computed by MarginsX.
Profile
| Field | Value |
|---|---|
| Ticker | CRRX on the Toronto Stock Exchange |
| Yahoo symbol | CRRX.TO |
| Sector | Life Sciences |
| Headquarters | Ontario |
| Listed | 2009-09-01 |
| Listing type | TSXV Grad |
| Shares outstanding | 63,409,019 |
| Also listed on | No interlisting on the TMX list |
| Index membership | Not in an S&P/TSX index per the TMX list |
| SEC CIK | No SEC filer matched on exact name with a Canadian address or US interlisting |
| Website | No company website on record |
Returns
| Window | Return |
|---|---|
| 1 day | +2.9% |
| 1 week | +3.9% |
| 1 month | -3.0% |
| 3 months | -1.5% |
| 6 months | -7.5% |
| Year to date | -15.7% |
| 1 year | 0.0% |
| From 52-week high | -18.5% |
| 52-week range | C$3.05 to C$3.95 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
72 documents in 3 types. Each title links to the document at its source.
Interim financial statements (7)
| Document | Type | Filed |
|---|---|---|
| Aug 28, 2018 Q2 Period Q2 2018 | Interim financial statements | 2018-08-28 |
| Dec 28, 2019 Annual Filings Period Q4 2019 | Quarterly report to shareholders | 2019-12-28 |
| Jul 28, 2019 Q2 Period Q2 2019 | Quarterly report to shareholders | 2019-07-28 |
| Mar 28, 2019 Q1 Period Q1 2019 | Quarterly report to shareholders | 2019-03-28 |
MD&A (22)
| Document | Type | Filed |
|---|---|---|
| Mar 4, 2025 Annual Filings Period Q4 2025 | MD&A (annual) | 2025-03-04 |
| Dec 5, 2024 Annual Filings Period Q4 2024 | MD&A (annual) | 2024-12-05 |
| Mar 7, 2023 Annual Filings Period Q4 2023 | MD&A (annual) | 2023-03-07 |
| Mar 9, 2022 Annual Filings Period FY2022 | MD&A (annual) | 2022-03-09 |
Other (43)
| Document | Type | Filed |
|---|---|---|
| CareRx Q3-26 Earnings Call – November 5, 2026 at 8:30 am ET | Earning Call Slides Period Q3 2026 | Investor presentation | 2026-11-05 |
| See our latest investor presentation | Investor presentation | 2026-09-18 |
| CareRx Q2-26 Earnings Call – July 30, 2026 at 8:30 am ET | Earning Call Slides Period Q2 2026 | Investor presentation | 2026-07-30 |
| CareRx Q1-26 Earnings Call – May 7, 2026 at 8:30 am ET | Earning Call Slides Period Q1 2026 | Investor presentation | 2026-05-07 |
Sources: Company investor-relations website (links only, documents not copied). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
No CIRO halt notices for this company in our data.
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| TSND | TerrAscend Corp. | TSX | C$204.1M | -20.6% | -36.5% |
| MSCL | Satellos Bioscience Inc. | TSX | C$202.4M | -4.0% | +14.7% |
| AIDX | HealWELL AI Inc. | TSX | C$201.6M | -16.7% | -49.6% |
| LOVE | Cannara Biotech Inc. | TSX | C$198.5M | -3.8% | +23.0% |
| CRDL | Cardiol Therapeutics Inc. | TSX | C$197.0M | -14.0% | 0.0% |
The app has the price chart, every filing, private raises and the full peer set for CRRX.
Open in the app